Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosecurity

    Harvard Medical School Closing Primate Research Center

    By Global Biodefense StaffApril 25, 2013
    Share
    Facebook LinkedIn Reddit Email

    Non-Human Primate (NHP) ResearchHarvard Medical School announced this week it will be drawing down operations of the New England Primate Research Center (NEPRC) rather than seek to renew a five-year federal grant to continue operations.

    The school indicated its leadership had begun to work with the National Institutes of Health (NIH) on a transition plan to end work at the facility within 12 to 24 months.

    The news came as somewhat of a surprise to the primate research community. School leaders acknowledged that the decision was extremely difficult in light of the groundbreaking research that has been conducted at the center over the past several decades.

    The current challenges and uncertainties of the external funding environment for scientific research were cited as a major factor in the decision. As Harvard Medical School leadership evaluated the long-term need to use its resources in the most effective manner across all of its missions, they came to the conclusion that winding down the operations of the NEPRC was more beneficial to the School than investing further resources in maintaining and renewing the NEPRC grant.

    Research accomplishments made possible by NEPRC research with nonhuman primates include:

    •  First unambiguous evidence that AIDS is caused by a virus.
    •  Discovery of simian immunodeficiency virus (SIV) and development of the first animal model of AIDS.
    •  Original demonstration that vaccine protection against AIDS is possible.
    •  Discovery of the oncogenic herpesvirus, Herpesvirus saimiri.
    •  First nonhuman primate models of colon cancer and inflammatory bowel disease.
    •  Evidence leading to the use of hydroxyurea to treat sickle cell anemia.
    •  Discovery of stunned myocardium and its role in myocardial ischemia.
    •  First animal model for progressive neurodegeneration in Parkinson’s disease.
    •  Development of improved brain imaging techniques for early diagnosis of Parkinson’s disease.
    •  Development of novel cellular and pharmacological strategies for treatment of Parkinson’s disease. 

    “We are extremely proud of the contributions the NEPRC has made to improving human heath over the past nearly 50 years,” said Jeffrey S. Flier, Dean of the Faculty of Medicine of Harvard University. “We believe primate research is critical to the future of biomedical research and the effective development of lifesaving therapies. The Center’s research focus on HIV, infectious disease and vaccines will continue to be effectively pursued through scientific programs throughout HMS.”

    Read at Harvard: HMS to Wind Down Operations at Primate Research Center
    Read at Science Insider: Harvard Medical School to Shutter Primate Research

    Animal Models
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleField Epidemiology Framework for Cooperative Biological Engagement
    Next Article Influenza Centers of Excellence Data Processing and Coordinating

    Related Stories

    Virginia Tech Lab Selected for National Partnership to Fight Emerging Diseases

    November 14, 2023

    NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox

    November 14, 2023

    COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule Discovery

    November 11, 2023

    APHIS Announces Funding for Tribes to Support Animal Disease Preparedness and Response

    October 24, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.